Laura Shawver, Capstan Therapeutics CEO

Backed by five phar­ma gi­ants and a crew of Penn su­per­stars, a start­up us­es mR­NA to cre­ate in vi­vo CAR-T — with a pro at the helm

Ear­li­er this year, Jonathan Ep­stein and oth­er sci­en­tists at Penn pub­lished a pa­per in Sci­ence that spelled out the in­trigu­ing re­sults …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.